The adverse effects of smoking are well known and documented. The effect of smokeless tobacco is less clear. Now a study from Sweden, published in Circulation, offers evidence that quitting smokeless tobacco after a heart attack is about as beneficial as quitting smoking. The results do not support the common view that smokeless tobacco is a safe alternative to smoking….
If You Snus, You Lose: Study Shows Benefits of Quitting Smokeless Tobacco
June 23, 2014 by Leave a Comment
FDA Safety Review Finds Small, Nonsignificant Increased Risk With Chantix (Varenicline)
December 12, 2012 by Leave a Comment
The FDA today updated its safety review of the smoking cessation drug varenicline (Chantix, Pfizer). A large meta-analysis, which the FDA had required Pfizer to perform, found a higher rate of major adverse cardiovascular events (MACE) in patients taking varenicline than in patients taking placebo. However, the increase in risk was very small and did not achieve statistical…
Recent Comments